Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of TNXP: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders4140−1
Shares14.4M12.0M−2.41M (−16.7%)
Value$5.81M$2.24M−$3.57M (−61.4%)

New holders (11)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to TNXP in Q1 2024
InstitutionSharesValue% of portfolio
Prudential Financial Inc134,800$25.1K0.00%
HCR Wealth Advisors100,000$18.6K0.00%
XTX Topco Ltd72,057$13.4K0.00%
Tower Research Capital LLC (TRC)34,406$6.40K0.00%
Virtu Financial LLC21,211$4.00K0.00%
Jane Street Group, LLC13,728$2.55K0.00%
Barry Investment Advisors, LLC13,326$2.48K0.00%
JPMorgan Chase & Co132$250.00%
Capital Advisors, Ltd. LLC393$00.00%
Central Trust Co1––
Allworth Financial LP1––

Sold out (12)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q4 2023 and filed for Q1 2024 without it.